Thembile Mzolo
Overview
Explore the profile of Thembile Mzolo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nolan T, Bhusal C, Hoberman A, Llapur C, Voloshyna O, Fink E, et al.
Clin Infect Dis
. 2024 Dec;
PMID: 39722560
Background: A MenABCWY vaccine containing 4CMenB and MenACWY-CRM vaccine components has been developed to protect against the five meningococcal serogroups that cause most invasive disease cases. Methods: In this phase...
2.
Vir Singh P, Tiberi P, Di Domenico G, Romolini V, Mzolo T, Costantini M, et al.
Drug Saf
. 2022 Nov;
46(1):99-108.
PMID: 36369456
Introduction: The currently licensed quadrivalent MenACWY-CRM conjugate vaccine presentation consists of two vials (lyophilized MenA and liquid MenCWY) to be reconstituted before injection. A new fully liquid, single-vial formulation has...
3.
Diez-Domingo J, Tinoco J, Poder A, Dinleyici E, Nell H, Salamanca de la Cueva I, et al.
Hum Vaccin Immunother
. 2021 Oct;
18(1):1981085.
PMID: 34614379
A fully liquid MenACWY-CRM vaccine presentation has been developed, modifying the meningococcal serogroup A (MenA) component from lyophilized to liquid. The safety and immunogenicity of the liquid presentation at the...
4.
Giuliani M, Biolchi A, Keshavan P, Moriondo M, Tomei S, Santini L, et al.
Hum Vaccin Immunother
. 2020 Dec;
17(5):1442-1449.
PMID: 33325757
An increase in invasive meningococcal disease (IMD) incidence was observed in Tuscany in 2015/2016, mainly due to hypervirulent clonal complex (cc) 11 strains. In a analysis, we assessed bactericidal activity...
5.
Tipton M, Daly W, Senders S, Block S, Lattanzi M, Mzolo T, et al.
Vaccine
. 2019 Sep;
37(42):6171-6179.
PMID: 31495595
Background: Vaccination strategies against bacterial meningitis vary across countries. In the United States, a single dose of quadrivalent meningococcal conjugate vaccine (MenACWY) is recommended at 11-12 years of age, with...
6.
Miao Y, Mzolo T, Pellegrini M
Infect Dis Ther
. 2019 Aug;
8(3):335-341.
PMID: 31377946
Introduction: Vaccines against human papillomavirus (HPV), tetanus, diphtheria, pertussis (Tdap) and Neisseria meningitidis are widely recommended in adolescents. A phase-4 observer-blind study was performed to investigate the impact of concomitant...
7.
Balje-Volkers C, Mzolo T, Talens E, IJzerman-Boon P, van den Heuvel E
Pharm Stat
. 2017 Nov;
17(1):12-24.
PMID: 29110389
Similarity in bioassays means that the test preparation behaves as a dilution of the standard preparation with respect to their biological effect. Thus, similarity must be investigated to confirm this...
8.
Zuma K, Mzolo T, Makonko E
Afr J AIDS Res
. 2015 Apr;
10(3):189-94.
PMID: 25859787
The research uses data from a representative national survey to explore the determinants of age at sexual debut among South African youths in the age group 15-24 years. A random...
9.
Mzolo T, Hendriks M, van den Heuvel E
Pharm Stat
. 2013 Oct;
12(6):375-84.
PMID: 24123711
This paper compares the ordinary unweighted average, weighted average, and maximum likelihood methods for estimating a common bioactivity from multiple parallel line bioassays. Some of these or similar methods are...
10.
Zuma K, Setswe G, Ketye T, Mzolo T, Rehle T, Mbelle N
Afr J Reprod Health
. 2011 Jan;
14(2):47-54.
PMID: 21243918
Age at sexual debut is an important determinant of HIV infection. The paper investigates the effects of age at sexual debut on sexual behaviour among South African youth. Among 2...